4
Changes in Ownership
Dianthus Therapeutics, Inc. /DE/ Filed Acc 0000950170-23-048022
Director bought 24,254 shares at an average $11.20 ($271,680)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Fairmount Funds Management LLC Director | 2023-09-12 | Purchase | +14,887 | $10.85 | $161,524 | 1,834,466 | I |
| Fairmount Funds Management LLC Director | 2023-09-13 | Purchase | +9,367 | $11.76 | $110,156 | 1,843,833 | I |
| Derivatives | |||||||
| Fairmount Funds Management LLC Director | 2023-09-11 | Grant or award · Stock Option (Right to Buy) | +6,500 | 6,500 | I | ||
| Open-market purchases · 24,254 sh · avg $11.20 · $271,680 | |||||||
Loading xslF345X05/ownership.xml…